Get started
vandmed

Long BNTX Call Options

Long
BioNTech SE (NASDAQ:BNTX)  
vandmed Updated   
NASDAQ:BNTX   BioNTech SE
Pivot Points
3
0
pivotpoints
BNTX appears to be breaking out on news from Europe in relation to COVID. Governments such as Austria are taking a much harder line and this should significantly increase demand (initial doses plus boosters).

Bought two sets of call options - Dec/17 and short term breakout Nov/26.
Comment:
Exited Nov/26 calls when trading at $362 at $26.31 per contract. 29x Risk-Reward Ratio on trade.

Will keep the Dec/17 calls
Comment:
Correction - exit was at $23.61 per contract so 26x Risk-Reward ratio.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.